BioNTech Hits Three-Year Low As Covid Vaccine Sales Plummet 65%, Missing Forecasts

BioNTech Hits Three-Year Low As Covid Vaccine Sales Plummet 65%, Missing Forecasts

BioNTech Hits Three-Year Low As Covid Vaccine Sales Plummet 65%, Missing Forecasts · Investor's Business Daily
Trade BNTX on Coinbase

BioNTech stock tumbled Wednesday after the Covid vaccine maker reported light fourth-quarter sales and profit.